Key result
Perfusion with the glucose oxidation stimulator dichloroacetate (DCA) acutely reversed cardiac function depression in isolated working diabetic rat hearts.
Why the study?
Does dichloroacetate improve cardiac function in isolated working hearts from diabetic rats?
Does dichloroacetate improve cardiac function in isolated working hearts from diabetic rats?
Stimulation of glucose oxidation with dichloroacetate acutely reverses cardiac dysfunction in isolated diabetic rat hearts, highlighting the role of metabolic derangements in diabetic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
DCA effects in diabetic rat hearts remain hypothesis-generating; should not inform clinical practice without human trials.
It is well established that cardiac dysfunction independent of atherosclerosis develops in both humans and animals with diabetes mellitus. The etiology is complex, involving many different processes, one of which may be increased fatty acid utilization and/or a concomitant decrease in glucose utilization by the diabetic heart. We compared control and 6-wk streptozotocin (STZ)-induced diabetic isolated working rat hearts and were able to demonstrate cardiac dysfunction in the diabetic as assessed by depressed heart rate (HR), heart rate peak systolic pressure product (HR.PSP), left ventricular developed pressure (LVDP), and rate of pressure rise (+dP/dt). Paralleling depressed cardiac function in the diabetic were hyperglycemia, hyperlipidemia, and decreased body weight gain compared with age-matched controls. The addition of free fatty acids, in the form of 1.2 mM palmitate, to the isolated working heart perfusate had no effect on either control or diabetic heart function, with the exception of a depressive effect on +dP/dt of diabetic hearts. But diabetic hearts perfused with palmitate-containing perfusate plus the glucose oxidation stimulator dichloroacetate (DCA) showed a marked improvement in function. HR and HR.PSP in spontaneously beating hearts, as well as LVDP and +dP/dt in paced hearts were all restored to control heart values in diabetic hearts perfused in the presence of DCA. Creatine phosphate and ATP levels were similar under all perfusion conditions, thus eliminating energy stores as the limiting factor in heart function. Results indicate that DCA will acutely reverse diabetic cardiac function depression. Therefore glucose oxidation depression in the diabetic heart may be a significant factor contributing to cardiac dysfunction.
No takes yet. Share an insight, caveat, or question.
Nicholl et al. (1991) studied Diabetes mellitus. Dichloroacetate (DCA) plus palmitate vs. Control hearts and diabetic hearts without DCA was evaluated on Cardiac function (HR, HR.PSP, LVDP, +dP/dt). Perfusion with the glucose oxidation stimulator dichloroacetate (DCA) acutely reversed cardiac function depression in isolated working diabetic rat hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: